SRXN1 and preeclampsia: While typically associated with cancer pathways, SRXN1 was found to be markedly downregulated in a murine model of preeclampsia, correlating with impaired trophoblast viability, invasion, and myometrial migration—features mediated through ferroptotic mechanisms [32].